Corbus Pharmaceuticals Holding Stock Analysis

Corbus Stock Analysis Notes

About 57.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 10.31. Corbus Pharmaceuticals had not issued any dividends in recent years. The entity had 1:30 split on the 14th of February 2023. Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. The company was incorporated in 2009 and is based in Norwood, Massachusetts. Corbus Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. For more info on Corbus Pharmaceuticals Holding please contact Yuval Cohen at 617 963 0100 or go to https://www.corbuspharma.com.

Corbus Pharmaceuticals Investment Alerts

Corbus Pharmaceuticals Upcoming and Recent Events

Corbus Largest EPS Surprises

View All Earnings Estimates

Corbus Pharmaceuticals Thematic Classifications

Corbus Stock Institutional Investors

Note, although Corbus Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Corbus Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 383.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Corbus Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Corbus Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Corbus Profitablity

Management Efficiency

Corbus Pharmaceuticals has return on total asset (ROA) of (0.5957) % which means that it has lost $0.5957 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4198) %, meaning that it created substantial loss on money invested by shareholders. Corbus Pharmaceuticals' management efficiency ratios could be used to measure how well Corbus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Corbus Pharmaceuticals' Return On Capital Employed is relatively stable compared to the past year. As of 04/19/2024, Return On Equity is likely to grow to 6.78, while Return On Tangible Assets are likely to drop (1.66). As of 04/19/2024, Liabilities And Stockholders Equity is likely to grow to about 50.5 M, while Total Current Liabilities is likely to drop slightly above 16.9 M.

Technical Drivers

As of the 19th of April, Corbus Pharmaceuticals shows the Mean Deviation of 11.02, risk adjusted performance of 0.1074, and Downside Deviation of 9.41. Corbus Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Corbus Pharmaceuticals Holding, which can be compared to its peers. Please confirm Corbus Pharmaceuticals standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Corbus Pharmaceuticals is priced correctly, providing market reflects its regular price of 39.24 per share. Given that Corbus Pharmaceuticals has jensen alpha of 4.78, we suggest you to validate Corbus Pharmaceuticals Holding's prevailing market performance to make sure the company can sustain itself at a future point.

Corbus Pharmaceuticals Price Movement Analysis

Corbus Pharmaceuticals Insider Trading Activities

Corbus Pharmaceuticals Predictive Daily Indicators

Corbus Pharmaceuticals Corporate Filings

Corbus Pharmaceuticals Forecast Models

Corbus Pharmaceuticals' time-series forecasting models are one of many Corbus Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Corbus Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Corbus Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Corbus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Corbus Pharmaceuticals. By using and applying Corbus Stock analysis, traders can create a robust methodology for identifying Corbus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Corbus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Corbus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Corbus Pharmaceuticals Holding stock analysis indicators help investors evaluate how Corbus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Corbus Pharmaceuticals shares will generate the highest return on investment. By understating and applying Corbus Pharmaceuticals stock analysis, traders can identify Corbus Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corbus Pharmaceuticals Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Corbus Pharmaceuticals information on this page should be used as a complementary analysis to other Corbus Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Corbus Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corbus Pharmaceuticals. If investors know Corbus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corbus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Corbus Pharmaceuticals is measured differently than its book value, which is the value of Corbus that is recorded on the company's balance sheet. Investors also form their own opinion of Corbus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Corbus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corbus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Corbus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Corbus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corbus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corbus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.